Nanotechnology-driven therapies for neurodegenerative diseases: a comprehensive review.

Autor: López-Espinosa J; Department of Neurosurgery & Center for Neuroregeneration, Houston, TX USA.; School of Medicine and Health Sciences of Tecnológico de Monterrey, Guadalajara, México., Park P; Department of Neurosurgery & Center for Neuroregeneration, Houston, TX USA., Holcomb M; Department of Neurosurgery & Center for Neuroregeneration, Houston, TX USA., Godin B; Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX USA.; Department of Obstetrics & Gynecology, Houston Methodist Hospital, Houston, TX USA.; Department of Obstetrics & Gynecology, Weill Cornell Medicine College, New York, NY USA.; Department of Biomedical Engineering, Texas A&M University, College Station, TX USA., Villapol S; Department of Neurosurgery & Center for Neuroregeneration, Houston, TX USA.; Department of Neuroscience in Neurological Surgery, Weill Cornell Medical College, New York, NY USA.

Publikováno v: Therapeutic delivery [Ther Deliv] 2024 Sep 19, pp. 1-28. Date of Electronic Publication: 2024 Sep 19.

Correction for partial volume averaging in the quantification of radiopaque nanomaterial-embedded resorbable polymers.

Autor: Melancon AD; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States of America.; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, 77030, United States of America., Jacobsen M; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, 77030, United States of America.; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States of America., Damasco J; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States of America., Perez J; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States of America., Bernardino M; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States of America., Valentin ES; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States of America., Court KA; Department of Nanomedicine, Houston Methodist Research Hospital, Houston, TX, 77030, United States of America., Godin B; Department of Nanomedicine, Houston Methodist Research Hospital, Houston, TX, 77030, United States of America., Layman R; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, 77030, United States of America.; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States of America., Melancon MP; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, 77030, United States of America.; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, United States of America.

Publikováno v: Biomedical physics & engineering express [Biomed Phys Eng Express] 2024 Aug 12; Vol. 10 (5). Date of Electronic Publication: 2024 Aug 12.

Mechanisms and Barriers in Nanomedicine: Progress in the Field and Future Directions.

Autor: Anchordoquy T; Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, the University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States., Artzi N; Brigham and Woman's Hospital, Department of Medicine, Division of Engineering in Medicine, Harvard Medical School, Boston, Massachusetts 02215, United States.; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, Massachusetts 02215, United States.; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts 02215, United States., Balyasnikova IV; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University; Northwestern Medicine Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, United States., Barenholz Y; Membrane and Liposome Research Lab, IMRIC, Hebrew University Hadassah Medical School, Jerusalem 9112102, Israel., La-Beck NM; Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, Texas 79601, United States., Brenner JS; Departments of Medicine and Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States., Chan WCW; Institute of Biomedical Engineering, University of Toronto, Rosebrugh Building, 164 College Street, Toronto, Ontario M5S 3G9, Canada.; Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto, Ontario M5S 3E1, Canada., Decuzzi P; Laboratory of Nanotechnology for Precision Medicine, Italian Institute of Technology, 16163 Genova, Italy., Exner AA; Departments of Radiology and Biomedical Engineering, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, United States., Gabizon A; The Helmsley Cancer Center, Shaare Zedek Medical Center and The Hebrew University of Jerusalem-Faculty of Medicine, Jerusalem, 9103102, Israel., Godin B; Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas 77030, United States.; Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston, Texas 77030, United States.; Department of Obstetrics and Gynecology, Weill Cornell Medicine College (WCMC), New York, New York 10065, United States.; Department of Biomedical Engineering, Texas A&M, College Station, Texas 7784,3 United States., Lai SK; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina 27599, United States., Lammers T; Department of Nanomedicine and Theranostics, Institute for Experimental Molecular Imaging, Center for Biohybrid Medical Systems, University Hospital RWTH Aachen, 52074 Aachen, Germany., Mitchell MJ; Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.; Penn Institute for RNA Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States., Moghimi SM; School of Pharmacy, Newcastle University, Newcastle upon Tyne NE1 7RU, U.K.; Translational and Clinical Research Institute, Faculty of Health and Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, U.K.; Colorado Center for Nanomedicine and Nanosafety, University of Colorado Anschutz Medical Center, Aurora, Colorado 80045, United States., Muzykantov VR; Department of Systems Pharmacology and Translational Therapeutics, The Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States., Peer D; Laboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 69978, Israel.; Department of Materials Sciences and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv, 69978, Israel.; Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, 69978, Israel.; Cancer Biology Research Center, Tel Aviv University, Tel Aviv, 69978, Israel., Nguyen J; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina 27599, United States., Popovtzer R; Faculty of Engineering and the Institute of Nanotechnology & Advanced Materials, Bar-Ilan University, 5290002 Ramat Gan, Israel., Ricco M; Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, the University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States., Serkova NJ; Department of Radiology, University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, Colorado 80045, United States., Singh R; Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27101, United States.; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina 27101, United States., Schroeder A; Department of Chemical Engineering, Technion, Israel Institute of Technology, Haifa 32000, Israel., Schwendeman AA; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48108; Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan 48108, United States., Straehla JP; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts 02115 United States.; Koch Institute for Integrative Cancer Research at MIT, Cambridge Massachusetts 02139 United States., Teesalu T; Laboratory of Precision and Nanomedicine, Institute of Biomedicine and Translational Medicine, University of Tartu, 50411 Tartu, Estonia., Tilden S; Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, the University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States., Simberg D; Department of Pharmaceutical Sciences, The Skaggs School of Pharmacy and Pharmaceutical Sciences, the University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, United States.

Publikováno v: ACS nano [ACS Nano] 2024 Jun 04; Vol. 18 (22), pp. 13983-13999. Date of Electronic Publication: 2024 May 20.

Macrophage Checkpoint Nanoimmunotherapy Has the Potential to Reduce Malignant Progression in Bioengineered In Vitro Models of Ovarian Cancer.

Autor: VandenHeuvel SN; Department of Biomedical Engineering, Texas A&M University, 3120 TAMU, College Station, Texas 77843, United States., Chau E; Department of Nanomedicine, Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, Texas 77030, United States., Mohapatra A; Department of Biomedical Engineering, Texas A&M University, 3120 TAMU, College Station, Texas 77843, United States., Dabbiru S; Department of Biomedical Engineering, Texas A&M University, 3120 TAMU, College Station, Texas 77843, United States., Roy S; Department of Biomedical Engineering, Texas A&M University, 3120 TAMU, College Station, Texas 77843, United States., O'Connell C; Department of Nanomedicine, Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, Texas 77030, United States.; School of Engineering Medicine, Texas A&M University, 1020 Holcombe Boulevard, Houston, Texas 77030, United States., Kamat A; Division of Gynecologic Oncology, Houston Methodist Hospital, 6550 Fannin Street, Houston, Texas 77030, United States.; Department of Obstetrics and Gynecology, Houston Methodist Hospital, 6550 Fannin Street, Houston, Texas 77030, United States.; Houston Methodist Neal Cancer Center, 6445 Main Street, Houston, Texas 77030, United States., Godin B; Department of Biomedical Engineering, Texas A&M University, 3120 TAMU, College Station, Texas 77843, United States.; Department of Nanomedicine, Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, Texas 77030, United States.; Department of Obstetrics and Gynecology, Houston Methodist Hospital, 6550 Fannin Street, Houston, Texas 77030, United States.; Houston Methodist Neal Cancer Center, 6445 Main Street, Houston, Texas 77030, United States., Raghavan SA; Department of Biomedical Engineering, Texas A&M University, 3120 TAMU, College Station, Texas 77843, United States.

Publikováno v: ACS applied bio materials [ACS Appl Bio Mater] 2024 Apr 01. Date of Electronic Publication: 2024 Apr 01.

Image-Guided Deployment and Monitoring of a Novel Tungsten Nanoparticle-Infused Radiopaque Absorbable Inferior Vena Cava Filter in a Swine Model.

Autor: San Valentin EM; Department of Interventional Radiology, the University of Texas MD Anderson Cancer Center, Houston, Texas., Damasco JA; Department of Interventional Radiology, the University of Texas MD Anderson Cancer Center, Houston, Texas., Bernardino M; Department of Interventional Radiology, the University of Texas MD Anderson Cancer Center, Houston, Texas., Court KA; Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas., Godin B; Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas., Canlas GM; Department of Chemistry, Lamar University, Beaumont, Texas., Melancon A; Department of Radiation Physics, the University of Texas MD Anderson Cancer Center, Houston, Texas., Chintalapani G; Advanced Therapies, Siemens Healthineers, Erlangen, Germany., Jacobsen MC; Department of Imaging Physics, the University of Texas MD Anderson Cancer Center, Houston, Texas., Norton W; Department of Veterinary Medicine and Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas., Layman RR; Department of Imaging Physics, the University of Texas MD Anderson Cancer Center, Houston, Texas., Fowlkes N; Department of Veterinary Medicine and Surgery, the University of Texas MD Anderson Cancer Center, Houston, Texas., Chen SR; Department of Interventional Radiology, the University of Texas MD Anderson Cancer Center, Houston, Texas., Huang SY; Department of Interventional Radiology, the University of Texas MD Anderson Cancer Center, Houston, Texas., Melancon MP; Department of Interventional Radiology, the University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: mmelancon@mdanderson.org.

Publikováno v: Journal of vascular and interventional radiology : JVIR [J Vasc Interv Radiol] 2024 Jan; Vol. 35 (1), pp. 113-121.e3. Date of Electronic Publication: 2023 Sep 09.